Fludeoxyglucose
These highlights do not include all the information needed to use Fludeoxyglucose F18 Injection safely and effectively. See full prescribing information for Fludeoxyglucose F18 Injection. Fludeoxyglucose F18 Injection Initial U.S. Approval: 2005
Approved
Approval ID
0ec2d4d1-b295-18dc-e054-00144ff88e88
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Dec 22, 2023
Manufacturers
FDA
MIPS Cyclotron & Radiochemistry Facility
DUNS: 964425834
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Fludeoxyglucose F18
PRODUCT DETAILS
NDC Product Code69587-001
Application NumberANDA204472
Marketing CategoryC73584
Route of AdministrationINTRAVENOUS
Effective DateDecember 22, 2023
Generic NameFludeoxyglucose F18
INGREDIENTS (1)
FLUDEOXYGLUCOSE F-18Active
Quantity: 300 mCi in 1 mL
Code: 0Z5B2CJX4D
Classification: ACTIB